Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of PZH2108 tablets for cancer pain in patients with tumor-related bone lesions
CTR20252775Phase 2Active
- Sponsor
- Zhangzhou Pien Tze Huang Pharmaceutical
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PZH2108 in cancer pain, sponsored by Zhangzhou Pien Tze Huang Pharmaceutical. Started Nov 2025; status: active.
02
Drugs
PZH2108
03
Conditions
cancer pain
Beyond the preview
Go deeper on CTR20252775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252775.